Work

Analyses des risques concurrents de progression systémique ou au niveau du système nerveux central chez des patients avec CBNPC EGFR muté ayant reçu de l’afatinib dans les études LUX-Lung 3, 6 et 7

Year: 2018

Type: article

Source: Revue des Maladies Respiratoires

DOI: 10.1016/j.rmr.2018.10.070

Authors: Y.L. Wu, J.C.H. Yang, V. Hirsh, K. O’byrne, N. Yamamoto, S. Popat, A. Tamiya, A. Märten, M. Schuler, N. Girard

Institutions: Guangdong General Hospital, Guangdong Academy of Medical Sciences, National Taiwan University Hospital, McGill University, Princess Alexandra Hospital, Wakayama Medical University, Royal Marsden Hospital, NHO Kinki Chuo Chest Medical Center, Boehringer Ingelheim (Germany), Essen University Hospital, University of Duisburg-Essen, Institut Curie

Language: French

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2906874751

FWCI:

Cites: 2

Cited by:

Related to: 10